EM1805F “Controlling Cholesterol” (IM GR-050418)
The purpose is to inform the audience about the mechanism that regulates the cholesterol content in blood, and to describe agents that lower blood cholesterol and reduce heart attacks.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Understand the feedback machinery that controls the level of cholesterol in blood and cells.
- Understand how certain drugs increase the number of low-density lipoprotein receptors in the liver and lower blood cholesterol.
- Understand the results of a recent study demonstrating that lowering of LDL with a monoclonal antibody against PCSK9 reduces the number of heart attacks and strokes.
- Explain to her or his patients why it is essential that they maintain control of their blood cholesterol levels
Michael S. Brown, M.D.
The W.A. (Monty) Moncrief Distinguished Chair in Cholesterol and Arteriosclerosis Research
Paul J. Thomas Professor of Molecular Genetics
Director, Jonsson Center for Molecular Genetics
Recipient of the Nobel Prize in Physiology or Medicine 1985
Donald W. Seldin Research Symposium Guest Lecturer
- 1.00 AMA